As a strategic collaborator, you’ll have the opportunity to co-own and develop customized patents within our expanding portfolio. Our core invention is protected by a provisional patent application and is progressing toward divisional filings—creating a strong foundation for intellectual property tailored to your expertise. Together, we’ll design a personalized new drug for your specific cancer biomarker target, helping establish meaningful exclusivity in your field.

Join us to advance breakthrough oncology innovation—transforming cancer care through personalized biomarker-driven approaches based on mitochondrial voltage and shaping the next generation of medicine.